Denali Advisors LLC Acquires 200 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Denali Advisors LLC raised its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.7% in the fourth quarter, HoldingsChannel.com reports. The firm owned 3,700 shares of the company’s stock after buying an additional 200 shares during the period. Denali Advisors LLC’s holdings in GE HealthCare Technologies were worth $289,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of GEHC. Assenagon Asset Management S.A. grew its stake in shares of GE HealthCare Technologies by 10.1% in the 3rd quarter. Assenagon Asset Management S.A. now owns 13,735 shares of the company’s stock worth $1,289,000 after acquiring an additional 1,256 shares in the last quarter. Nisa Investment Advisors LLC grew its stake in shares of GE HealthCare Technologies by 2.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 76,349 shares of the company’s stock worth $7,165,000 after acquiring an additional 1,920 shares in the last quarter. Valmark Advisers Inc. bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter worth $222,000. Golden State Equity Partners bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter worth $532,000. Finally, Folger Nolan Fleming Douglas Capital Management Inc. bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter worth $221,000. Institutional investors own 82.06% of the company’s stock.

Analysts Set New Price Targets

GEHC has been the topic of a number of research analyst reports. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price target for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Citigroup boosted their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. Finally, Wells Fargo & Company boosted their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $97.67.

GE HealthCare Technologies Price Performance

NASDAQ GEHC opened at $89.40 on Friday. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.80. The company has a market cap of $40.88 billion, a PE ratio of 20.65, a price-to-earnings-growth ratio of 3.19 and a beta of 1.15. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The firm’s 50-day simple moving average is $86.00 and its two-hundred day simple moving average is $86.07.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. Research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.